#Immunoassay #Reagents #Biotechnology #LifeScience #Biochemistry #Research #LabLife #Science #AssayDevelopment #Antibodies #Proteins #DiagnosticTesting #ClinicalChemistry #Laboratory #MedicalResearch #Healthcare #ELISA #Fluorescence #Chemiluminescence #Immunology #MolecularBiology #CellBiology #AnalyticalChemistry #Microbiology #BiomedicalScience #Diagnostics #Innovation #Technology #PrecisionMedicine #Biopharmaceuticals #BiomedicalResearch #Bioreagents #Pathology #Immunodiagnosis #Antigen #AntibodyDetection #ResearchAndDevelopment #ClinicalTrials #HealthTech #Biomarkers #MedicalDevices #PrecisionHealth #BiomedicalEngineering #Therapeutics #Pharmaceuticals #DrugDiscovery #Genomics #Virology #Microarray #PCR #FlowCytometry #Biosensors #Nanotechnology #Immunochemistry #MedicalDevices #MedicalTechnology #HealthInnovation #BiotechStartup #HealthTechInnovation #MedicalInnovation #HealthScience #BiomedicalDevices #HealthcareTechnology #LabResearch #Bioassay #Bioinformatics #ClinicalLaboratory #AssayKit #PointOfCare #LaboratoryMedicine #DiagnosticKits #Chemistry #BiomedicalDiagnosis #BiochemicalAnalysis #Immunodiagnostics #InfectiousDiseases #BiomedicalTechnology #DiagnosticInstruments #HealthcareInnovation #MolecularDiagnostics #MedicalInstruments #InVitroDiagnostics #BiomedicalInnovation #ClinicalChemistry #BiomedicalTesting #BiomedicalDevices #HealthcareTechnology #DiagnosticSolutions #BiomedicalSolutions #LabEquipment #HealthcareDevices #BiomedicalDevices #DiagnosticDevices #MedicalDevices #BiomedicalTools #LabTools #ResearchTools #LabSupplies #LaboratoryEquipment #ResearchEquipment

#Immunoassay #Reagents #Biotechnology #LifeScience #Biochemistry #Research #LabLife #Science #AssayDevelopment #Antibodies #Proteins #DiagnosticTesting #ClinicalChemistry #Laboratory #MedicalResearch #Healthcare #ELISA #Fluorescence #Chemiluminescence #Immunology #MolecularBiology #CellBiology #AnalyticalChemistry #Microbiology #BiomedicalScience #Diagnostics #Innovation #Technology #PrecisionMedicine #Biopharmaceuticals #BiomedicalResearch #Bioreagents #Pathology #Immunodiagnosis #Antigen #AntibodyDetection #ResearchAndDevelopment #ClinicalTrials #HealthTech #Biomarkers #MedicalDevices #PrecisionHealth #BiomedicalEngineering #Therapeutics #Pharmaceuticals #DrugDiscovery #Genomics #Virology #Microarray #PCR #FlowCytometry #Biosensors #Nanotechnology #Immunochemistry #MedicalDevices #MedicalTechnology #HealthInnovation #BiotechStartup #HealthTechInnovation #MedicalInnovation #HealthScience #BiomedicalDevices #HealthcareTechnology #LabResearch #Bioassay #Bioinformatics #ClinicalLaboratory #AssayKit #PointOfCare #LaboratoryMedicine #DiagnosticKits #Chemistry #BiomedicalDiagnosis #BiochemicalAnalysis #Immunodiagnostics #InfectiousDiseases #BiomedicalTechnology #DiagnosticInstruments #HealthcareInnovation #MolecularDiagnostics #MedicalInstruments #InVitroDiagnostics #BiomedicalInnovation #ClinicalChemistry #BiomedicalTesting #BiomedicalDevices #HealthcareTechnology #DiagnosticSolutions #BiomedicalSolutions #LabEquipment #HealthcareDevices #BiomedicalDevices #DiagnosticDevices #MedicalDevices #BiomedicalTools #LabTools #ResearchTools #LabSupplies #LaboratoryEquipment #ResearchEquipment

Getein 1180 Immunofluorescence Quantitative Analyzer is used to measure the concentration of biomarkers in human whole blood, serum, plasma, urine, nasal swab, or saliva samples. Getein 1180 Immunofluorescence Quantitative Analyzer (hereinafter called Getein 1180) is an analyzer for processing and analysis of Getein test kits including biomarkers for cardiovascular diseases, renal function, inflammation, fertility, diabetes mellitus, bone metabolism, tumor, and thyroid function, etc. Getein 1180 is used to measure the concentration of biomarkers in human whole blood, serum, plasma, urine, nasal swab, or saliva samples. The results can be used as an aid in clinical diagnosis of laboratory and point-of-care testing. It is applicable in Emergency, Clinical labs, Outpatient, ICU, CCU, Cardiology, Ambulance, Inpatient Wards, etc.

At Mindray we pride ourselves on our dedication and experience in developing better solutions for small labs. Our new line of 3-part hematology analyzers is the culmination of that effort. Compact yet powerful, full featured yet affordable, the BC-20s is what a 3-part analyzer should be. Features CBC+3-DIFF, 19 parameters+3 histograms Throughput:40 samples per hour Intuitive operation system with 8.4 inch TFT touch screen Open vial sampling 200,000 results storage with histograms Original QC, calibrators and reagents Product Specification Instrument Name Haematology Analyzer Model Name/Number BC20s Usage/Application Laboratory Brand Mindray Automation Fully Automatic Operation Mode Fully Automatic

The advanced BC-6800Plus not only provides more reliable routine CBC plus 5-part DIFF results, but also has a higher throughput of up to 200 samples per hour. Based on the new SF Cube technology platform, the BC-6800Plus could provide more reliable blood cell results and abnormal cells flagging results with anticipated warning messages, exceeding clinicians’ expectations and setting a new standard for blood analysis. SF Cube Technology With the newly designed opticals and reagent systems, the SF Cube technology can help doctors to better differentiate the clusters of cells, which is the key to revealing more abnormal cells. NRBC result in every CBC In WNB scattergram, BC-6800Plus provides NRBC, Basophils and WBC-N* results. It means that the actual number of NRBCs can be measured in routine CBC, if they are present in the sample. Basophils are counted in this counting channel with NRBC results. Basophil and NRBC results are generated on BC-6800Plus without extra reagent or cost. NLR parameter in each CBC+DIFF Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample. In laboratory medicine, NLR is used as a marker of subclinical inflammation. According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients. More accurate RET and PLT-O result By utilizing the new fluorescent dye, the reticulocytes and platelets are more specific stained with stronger fluorescent signal, that brings more reliable reticulocyte and platelet results. Automatic Rerun & Reflex Should the sample results trigger the criteria, the sample rack can automatically step back for a “rerun” or “reflex” check. 200 test/hour BC-6800Plus can load up to 100 samples at a time and offers a throughput of up to 200 tests per hour.

The OnSite Troponin I Combo Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of cardiac Troponin I (cTnI) in human serum, plasma or whole blood at a level equal to or higher than 1 ng/mL. It can be performed within 15 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite Troponin I Combo Rapid Test is intended to be used by healthcare professionals as an aid in the diagnosis of acute myocardial infarction (AMI). Any use or interpretation of this preliminary test result must also rely on patient’s symptoms and the professional judgment of a physician. A more precise test method such as an instrument method must be used to confirm the test result obtained by this device. Normally the level of cTnI in the blood is very low. cTnI is released into the blood stream in forms of free cTnI and cTnI-C-T complex at 4-6 hours after myocardial cell damage. The elevated level of cTnI could be as high as 50 ng/mL during 60-80 hours after AMI and remains detectable for up to 10-14 days post AMI. Therefore, circulating cTnI is a specific and sensitive marker for AMI. Clinical performance: Relative Sensitivity: 95.8% (95% CI: 91.5-97.9%) compared to a reference CLIA Relative Specificity: 99.7% (95% CI: 98.8-99.9%) Analytical sensitivity: The detection limit of cTnI is 1.0 ng/mL or greater in serum, plasma or whole blood specimen Cross-reactivity: No cross reactivity with 10 µg/mL skeletal muscle TnI, 2,000 ng/mL cardiac muscle TnT, 20 µg/mL cardiac muscle Myosin Dose hook effect: No hook effect was observed for cTnI at concentrations up to 3,521 µg/mL Interference: No interference was seen with 20 mg/dl Acetaminophen, 20 mg/dl Acetylsalicylic acid, 10.5 g/dl Albumin, 20 mg/dl Ascorbic acid, 1,000 mg/dl Bilirubin, 20 mg/dl Caffeine, 800 mg/dl Cholesterol, 200 mg/dl Creatinine, 20 mg/dl Gentistic acid, 1,000 mg/dl Hemoglobin, 600 mg/dl Oxilic acid, 1,600 mg/dl Triglycerides Shelf life: 24 months Individually sealed foil pouches containing: One cassette device One desiccant Plastic droppers Sample diluent (REF SB-R3002, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Insert MedlinePlus: Troponin Test Poster

The OnSite hCG Combo Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG in human serum, plasma and urine. It can be performed within 5-10 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite hCG Combo Rapid Test is not intended for quantitative results, nor for over the counter (OTC) sales. It is intended to meet all requirements for yielding rapid, easily read, qualitative results for the purpose of early pregnancy detection via assay of hCG, a placental hormone that may be present in human serum, plasma or urine. The hCG detection limit the OnSite hCG Combo Rapid Test is 12.5 mIU/mL in serum or plasma specimen, and 25 mIU/mL in urine specimen. It is designed for professional use only, and provides only preliminary analytical data. For a final diagnosis of pregnancy, a more specific alternative clinical method must be used to obtain a confirmed analytical result. Clinical accuracy: In comparison with a reference chemiluminecsence or ELISA, hCG detection is 100% sensitivity and 100% specificity in urine specimens 100% sensitivity and 99.5% specificity in serum specimens Analytical sensitivity: 100% positive detection rate at 12.5 mIU/mL in serum/plasma specimens and 100% positive detection rate at 25 mIU/mL in urine specimens Analytical specificity: no cross reactivity with 1,000 mIU/mL human luteinizing hormone (hLH), 1,000 mIU/mL human follicle stimulating hormone (hFSH), and 1,000 mIU/mL human thyroid stimulating hormone (hTSH) Dose hook effect: no dose hook effect was observed for hCG at concentrations up to 500,000 mIU/mL in urine specimens Interference: No interference was seen with 35 biological and chemical analytes commonly found in OTC, prescriptions or abuse drugs in urine or serum/plasma specimens, as well as pH 4-9 (see detail in the package insert) Shelf life: 24 month Kit box package: 1. Individually sealed foil pouches containing; a. One dip strip device b. One desiccant 2. One package insert (instruction for use) Tube package: 1. Strip Package 2. One desiccant 3. One package insert (instruction for use) CTK Products at a Glance Drugs.com: Overview of Human Chorionic Gonadotropin Inserts

The OnSite Leptospira IgG/IgM Combo Rapid Test is a lateral flow chromatographic immunoassay that can be performed within 15-20 minutes by minimally skilled personnel, and without the use of laboratory equipment. This test is intended to be used for the simultaneous detection and differentiation of IgG and IgM antibodies to Leptospira interrogans (L. interrogans) in human serum, plasma or whole blood. It is intended to be used as a screening test by professionals, and provides a preliminary test result to aid in the diagnosis of infection with L. interrogans. Any interpretation or use of this test result must also rely on other clinical findings as well as on the professional judgment of health care providers. Recommended for use: Any person presenting with clinical signs or symptoms consistent with acute infection with interrogans including: high fever, headache, chills, muscle aches, vomiting, jaundice, red eyes, abdominal pain, diarrhea, skin rash After exposure to a known contaminated source Accuracy: 100% specificity and 100% sensitivity in comparison with a reference rapid test on the market Cross Reactivity: No false positive results were observed on specimens from TP, HIV, Dengue, TB, Typhoid Ab , HBsAg, HCV Ab, HEV Ab, H.P Ab, HAV, HCG, RF, ANA, HAMA Interference: No interference were seen with substances: Salicylic acid: 4.34 mmol/L; Glucose: 55 mmol/L; Sodium citrate: 3.8 %; Heparin: 3,000 U/L; Creatinine: 442 μmol/L; Bilirubin: 20 mg/dL; EDTA: 3.4 μmol/L; Hemoglobin: 2g/L; Human IgG: 1000 mg/dL; AlbuminL 60 g/L Shelf life: 24 month Individually sealed foil pouches containing: One cassette device One desiccant 5 μL capillary tubes Sample diluent (REF SB-R0101, 5 mL/bottle) One package insert (instruction for use) CTK Products at a Glance Inserts U.S. CDC Leptospira Homepage: About Leptospira WHO: Leptospirosis Fact Sheets

The OnSite hCG Combo Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG in human serum, plasma and urine. It can be performed within 5-10 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite hCG Combo Rapid Test is not intended for quantitative results, nor for over the counter (OTC) sales. It is intended to meet all requirements for yielding rapid, easily read, qualitative results for the purpose of early pregnancy detection via assay of hCG, a placental hormone that may be present in human serum, plasma or urine. The hCG detection limit of the OnSite hCG Combo Rapid Test is 12.5 mIU/mL in serum or plasma specimen, and 25 mIU/mL in urine specimen. It is designed for professional use only, and provides only preliminary analytical data. For a final diagnosis of pregnancy, a more specific alternative clinical method must be used to obtain a confirmed analytical result. Clinical accuracy: In comparison with a reference chemiluminecsence or ELISA, hCG detection is 100% sensitivity and 100% specificity in urine specimens 100% sensitivity and 99.1% specificity in serum specimens Analytical sensitivity: 100% positive detection rate at 12.5 mIU/mL in serum/plasma specimens and 100% positive detection rate at 25 mIU/mL in urine specimens Analytical specificity: no cross reactivity with 1,000 mIU/mL human luteinizing hormone (hLH), 1,000 mIU/mL human follicle stimulating hormone (hFSH), and 1,000 mIU/mL human thyroid stimulating hormone (hTSH) Dose hook effect: no dose hook effect was observed for hCG at concentrations up to 500,000 mIU/mL in urine specimens Interference: No interference was seen with 35 biological and chemical analytes commonly found in OTC, prescriptions or abuse drugs in urine or serum/plasma specimens, as well as pH 4-9 (see detail in the package insert) Shelf life: 24 month Individually sealed foil pouches containi a. One cassette device b. One plastic dropper c. One desiccant One package insert (instruction for use) CTK Products at a Glance Drugs.com: Overview of Human Chorionic Gonadotropin Inserts CATALOG # PRODUCT QUANTITY SPECIMEN R1001C hCG Combo Rapid Test CE 30/kit S/Urine OTHER PRODUCTS YOU MIGHT BE INTERESTED IN.. CATALOG # PRODUCT QUANTITY SPECIMEN R1001S hCG Combo Rapid Test (Strip) CE 50/kit, 100/kit S/Urine